Value-Based Insurance Design: Embracing Value Over Cost Alone
Value Based Insurance Design: Maintaining a Focus on Health in an Era of Cost Containment
In this commentary, our Co-Editors-in-Chief advocate valuebased principles that align incentives to encourage use of high value services as an important tool in healthcare reform.
The Co-Pay Connection - Dr. A. Mark Fendrick of the University of Michigan
Dr. A. Mark Fendrick explains the concept of Value-Based Insurance Design (VBID) and how it works.
"Fiscally Responsible, Clinically Sensitive" Cost Sharing: Contain Costs While Preserving Quality
Value-based Insurance Design: Aligning Incentives to Bridge the Divide Between Quality Improvement and Cost Containment
The Role of Gastroprotection in Patients on NSAID Therapy
Rising Out-of-pocket Costs in Disease Management Programs
Value-based Insurance Design: A "Clinically Sensitive" Approach to Preserve Quality of Care and Contain Costs
Univariate Solutions in a Multivariate World: Can We Afford to Practice as in the "good old days"?
COX-2 Inhibitor Use After Vioxx: Careful Balance or End of the Rope?
Acute Exacerbation of Chronic Bronchitis: A Primary Care Consensus Guideline
Taking Stock at 2 Years - Continuing the Journey
Improving Cancer Screening Adherence: Using the "Teachable Moment" as a Delivery Setting for Educational Interventions
Mechanisms to Improve Pharmaceutical Use in Managed Care: To Study Controls, Control the Studies [Please]
Effect of Off-Label Use of Oncology Drugs on Pharmaceutical Costs: The Rituximab Experience
Cost-Effective Use of NSAIDs: Issues Pertinent to Coxib Use in Managed Care
A Word From the New Editors
Coronary Artery Bypass Grafting in Octogenarians: Clinical and Economic Outcomes at Community-Based Healthcare Facilities
Diagnostic Testing or Empirical Neuraminidase Inhibitor Therapy for Patients with Influenza-Like Illness: What a Difference a Day Makes
A New Method for Determining Patient Payments for Outpatient Drugs
A Benefit-Based Copay for Prescription Drugs: Patient Contribution Based on Total Benefits, Not Drug Acquisition Cost
Decomposing Pharmaceutical Cost Growth in Different Types of Health Plans
The Costs of Cancer to a Major Employer in the United States: A Case-Control Analysis
Access to Innovative Treatment of Erectile Dysfunction: Clinical, Economic, and Quality-of-Life Considerations
"We Got Mail": Electronic Communication Between Physicians and Patients
Diagnostic Testing for Influenza: Review of Current Status and Implications of Newer Treatment Options
Differences in Physician Compensation for Cardiovascular Services by Age, Sex, and Race
Understanding the Behavioral Response to Medical Innovation
Correspondence regarding, "Diagnosis and Eradication of Helicobacter pylori in the Management of Peptic Ulcer Disease: A Decision Analysis Model"
